Akari Therapeutics ADR (AKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,870 | -2,999 | 1,001 | -17,748 | -10,856 |
| Depreciation Amortization | 3 | N/A | 1 | 4 | 2 |
| Accounts payable and accrued liabilities | N/A | 79 | N/A | N/A | N/A |
| Other Working Capital | -1,059 | -919 | -563 | 822 | -2,854 |
| Other Operating Activity | -5,097 | -5,735 | -5,319 | -4,582 | 85 |
| Operating Cash Flow | $-12,023 | $-9,574 | $-4,880 | $-21,504 | $-13,623 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3,503 | 3,503 | 3,212 | 25,288 | 12,367 |
| Financing Cash Flow | $3,503 | $3,503 | $3,212 | $25,288 | $12,367 |
| Exchange Rate Effect | 1 | 2 | N/A | 105 | 47 |
| Beginning Cash Position | 13,250 | 13,250 | 13,250 | 9,361 | 9,361 |
| End Cash Position | 4,731 | 7,181 | 11,582 | 13,250 | 8,151 |
| Net Cash Flow | $-8,519 | $-6,069 | $-1,668 | $3,889 | $-1,210 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,023 | -9,574 | -4,880 | -21,504 | -13,623 |
| Free Cash Flow | -12,023 | -9,574 | -4,880 | -21,504 | -13,623 |